The treatment of Age-Related Cognitive Decline & Benign Paroxysmal Positional Vertigo with vitamins

Age-Related Cognitive Decline and Benign Paroxysmal Positional Vertigo: Mitamins custom make quality formulas for the treatment of Age-Related Cognitive Decline & Benign Paroxysmal Positional Vertigo with vitamins. A Age-Related Cognitive Decline & Benign Paroxysmal Positional Vertigo formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Age-Related Cognitive Decline and Benign Paroxysmal Positional Vertigo

  • Amount Per Serving
    % DV
    Vitamin C
    500
    mg
    833%
    Vitamin E
    400
    IU
    1333%
    Thiamin
    150
    mg
    10000%
    Riboflavin
    125
    mg
    7353%
    Niacin
    125
    mg
    625%
    Vitamin B6
    150
    mg
    7500%
    Folate
    800
    mcg
    200%
    Vitamin B12
    150
    mcg
    2500%
    Biotin
    150
    mcg
    50%
  • Amount Per Serving
    % DV
    Pantothenic Acid
    125
    mg
    1250%
    Choline Bitartrate
    125
    mg
    *
    Inositol
    125
    mg
    *
    PABA
    125
    mg
    *
    Ginkgo Extract
    120
    mg
    *
    Acetyl L-Carnitine
    100
    mg
    *
    Huperzine A
    100
    mcg
    *
    Phosphatidylserine
    100
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Age-Related Cognitive Decline and Benign Paroxysmal Positional Vertigo
Serving Size:4-5

Age-Related Cognitive Decline and Benign Paroxysmal Positional Vertigo Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
NeurogesX' NGX 4010 MAA Filed And Accepted For Review By EMEA For Treatment Of Peripheral Neuropathic Pain
NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing novel pain management therapies, announced that the Marketing Authorization Application (MAA) submitted by NeurogesX for NGX-4010, the Company's lead product candidate for peripheral neuropathic pain, has been accepted for review by the European Medicines Agency (EMEA).
RCN Welcomes New NHS Pension Scheme Arrangements
As NHS Employers and trade unions announce details of the new NHS Pension scheme arrangements, the Royal College of Nursing (RCN), has expressed delight at the outcome. Dr. Peter Carter, General Secretary of the RCN, said: "We are very pleased with the new arrangements for the NHS Pension Scheme in England and Wales. The announcement today is the culmination of four years hard work and negotiation between NHS Employers, the RCN and other healthcare trade unions.
This information concerning the support of Age-Related Cognitive Decline and Benign Paroxysmal Positional Vertigo treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments